SCHEMBL22635907

SCHEMBL22635907

CCCCCC12CCC(CNC1)N2C(N)=O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 1/20 0.31
▸ GNAO1 P09471 1/20 0.31
▸ GNAI1 P63096 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22636087 0.70 — —
SCHEMBL5217485 0.66 BCHE (0.35) GNAI3GNAO1GNAI1
SCHEMBL11044814 0.62 GAA (0.33) —
SCHEMBL11784129 0.59 SLC6A2 (0.44) —
SCHEMBL6439468 0.59 KDM4E (0.42) GNAI3GNAO1GNAI1
SCHEMBL613082 0.58 CYP4F2 (0.38) —
SCHEMBL5736616 0.58 L3MBTL1 (0.34) GNAI3GNAO1GNAI1
SCHEMBL9603340 0.58 GNAI3 (0.41) GNAI3GNAO1GNAI1
SCHEMBL7197775 0.57 CYP4F2 (0.41) —
SCHEMBL5031163 0.57 CYP4F2 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3965766-A1 COMBINATION OF AN ?2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA Bayer Aktiengesellschaft (DE) 2022-03-16 — — EP disclosed
WO-2020225185-A1 COMBINATION OF AN α2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA BAYER AKTIENGESELLSCHAFT (DE) 2020-11-12 — — WO disclosed
Send feedback